By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today announced deals with the Institute of Medical Microbiology at the University of Zurich, Francisco Soria Melguizo, and Viollier covering the MALDI Biotyper.

The collaboration with IMM focuses on the field of coryneform bacteria, actinomycetes, fastidious gram negative bacteria, and molds. The institute, which is the Swiss national reference center for mycobacteria, is using the MALDI Biotyper as its next-generation, rapid microbial identification system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.